Cabot Croissance future
Future contrôle des critères 4/6
Cabot devrait augmenter ses bénéfices et son chiffre d'affaires de 57.8% et de 3.7% par an respectivement. Le BPA devrait croître de de 58.9% par an. Le rendement des capitaux propres devrait être 21.2% dans 3 ans.
Informations clés
57.8%
Taux de croissance des bénéfices
58.88%
Taux de croissance du BPA
| Chemicals croissance des bénéfices | 21.6% |
| Taux de croissance des recettes | 3.7% |
| Rendement futur des capitaux propres | 21.18% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 23 Aug 2026 |
Mises à jour récentes de la croissance future
Recent updates
Mise à jour du récit • Aug 16
CBT: Rising Carbon Black Concerns Will Drive A Weaker Future Profile
Cabot's analyst price target has moved up from $70.37 to $78.00, with analysts pointing to updated views on revenue growth, profitability, and P/E assumptions following recent research that includes higher price objectives of $90 and $100, along with positive commentary on the battery materials and Performance Chemicals businesses. Analyst Commentary Recent research on Cabot has centered on how the stock trades relative to its P/E assumptions and perceived growth potential in key businesses such as battery materials and Performance Chemicals.Seeking Alpha • Aug 04
Cabot Corporation: Successful Returns, Downgrading Into 2027-2028E (Downgrade)
Summary Cabot Corporation is now fairly valued after a period of significant undervaluation and strong operational outperformance. I downgrade CBT to Hold with a new price target of $82/share, as the current upside is limited following a 20-30% rally. CBT’s disciplined capital allocation, low leverage, and resilient margins underpin its stability despite cyclical end-market pressures. Future growth hinges on recovery in reinforcement materials and continued strength in performance chemicals, but macro risks constrain further upside. Read the full article on Seeking AlphaNouveau récit • Aug 02
Battery Materials Competition And Cost Pressures Will Limit Long-Term Earnings Potential
Catalysts About Cabot Cabot Corporation produces specialty chemicals and materials including reinforcement materials, performance chemicals and battery materials that serve a range of industrial and energy storage applications. What are the underlying business or industry changes driving this perspective?
Mise à jour du récit • Jun 26
CBT: Battery Materials And Buybacks Will Shape Balanced Medium-Term Outlook
Analysts have nudged their fair value estimate for Cabot higher to $88.50 from $85.67, citing updated price targets in the $70 to $98 range and renewed attention on the company’s battery materials, Reinforcement Materials, and Performance Chemicals businesses. Analyst Commentary Recent Street commentary on Cabot gives a mixed but useful read on how professionals are weighing the company’s earnings potential, valuation, and execution across its key segments, especially battery materials, Reinforcement Materials, and Performance Chemicals.
Nouveau récit • Jun 23
Battery And Data Center Demand Will Drive Long-Term Upside Potential
Catalysts About Cabot Cabot develops specialty materials, including reinforcement and performance chemicals used across tires, batteries and broader industrial applications. What are the underlying business or industry changes driving this perspective?Article d’analyse • Jun 21
Cabot (CBT) Stock Could Be 7.2% Overvalued After Sixth Straight EcoVadis Platinum Rating
Cabot (CBT) has drawn fresh attention after receiving a platinum rating from EcoVadis for the sixth consecutive year, placing the company among the top 1% of peers in environmental, social, and governance practices. See our latest analysis for Cabot. The EcoVadis recognition has arrived during a strong run in Cabot’s stock, with a 34.09% 3 month share price return and a 28.47% 1 year total shareholder return, which may indicate building momentum rather than a short lived spike. If Cabot’s...Nouveau récit • Jun 09
Battery And Data Center Demand Will Support A Steady Long Term Materials Story
Catalysts About Cabot Cabot develops and supplies specialty materials, including reinforcement materials and performance chemicals used across batteries, tires, data centers and infrastructure applications. What are the underlying business or industry changes driving this perspective?Article d’analyse • Nov 03
Should You Think About Buying Cabot Corporation (NYSE:CBT) Now?
While Cabot Corporation ( NYSE:CBT ) might not have the largest market cap around , it saw significant share price...Article d’analyse • Sep 11
Cabot Corporation (NYSE:CBT) Screens Well But There Might Be A Catch
With a price-to-earnings (or "P/E") ratio of 10.1x Cabot Corporation ( NYSE:CBT ) may be sending bullish signals at the...Article d’analyse • Jul 20
Is Cabot Corporation (NYSE:CBT) Trading At A 36% Discount?
Key Insights Cabot's estimated fair value is US$117 based on 2 Stage Free Cash Flow to Equity Cabot's US$74.90 share...Article d’analyse • Jun 23
Shareholders Would Enjoy A Repeat Of Cabot's (NYSE:CBT) Recent Growth In Returns
There are a few key trends to look for if we want to identify the next multi-bagger. Ideally, a business will show two...Article d’analyse • Apr 25
These 4 Measures Indicate That Cabot (NYSE:CBT) Is Using Debt Reasonably Well
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Apr 10
Cabot Corporation's (NYSE:CBT) Intrinsic Value Is Potentially 56% Above Its Share Price
Key Insights The projected fair value for Cabot is US$126 based on 2 Stage Free Cash Flow to Equity Cabot is estimated...Article d’analyse • Mar 12
A Piece Of The Puzzle Missing From Cabot Corporation's (NYSE:CBT) Share Price
Cabot Corporation's ( NYSE:CBT ) price-to-earnings (or "P/E") ratio of 11x might make it look like a buy right now...Seeking Alpha • Feb 13
Cabot Corporation: Reinforcing Positive Shareholder Value
Summary Cabot Corporation outperforms its sector, offering growth and income opportunities, making it a strong buy candidate. CBT's two segments, Reinforcement Materials and Performance Chemicals, show impressive EBIT margin growth and revenue recovery. CBT's growing EPS, strong cash flow, and aggressive share buyback program enhance its financial resilience and shareholder value. Trading near support levels, CBT offers good upside potential with a forward yield of 2%, despite potential tariff policy risks. Read the full article on Seeking AlphaSeeking Alpha • Jan 30
Cabot: Eyeing Up A Bearish Position As We Approach Q1 Earnings (Technical Analysis)
Summary Cabot Corporation had a recent 25% drop and bearish MACD crossover, signaling potential technical weakness. The Reinforcement Materials segment continues to drive growth, but recent EPS and revenue revisions indicate challenges ahead. Fiscal 2024 revenue growth was flat, contrasting with a 5-year average of 4.59%, raising concerns about sustaining double-digit EPS growth. We expect earnings growth in Reinforcement Materials and a recovery in Performance Chemicals, but revenue growth remains crucial for CBT's long-term success. Read the full article on Seeking AlphaArticle d’analyse • Jan 29
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), might not be a large cap stock, but it received a lot of attention from a substantial...Article d’analyse • Jan 15
Is Cabot (NYSE:CBT) Using Too Much Debt?
Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...Article d’analyse • Jan 02
Returns On Capital Are A Standout For Cabot (NYSE:CBT)
Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...Article d’analyse • Dec 06
Cabot Corporation (NYSE:CBT) Shares Could Be 31% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Cabot is US$150 based on 2 Stage Free Cash Flow to Equity Current share price...Seeking Alpha • Nov 14
Cabot: Less Than 5% Annualized Upside
Summary Cabot Corporation has delivered a 50% total return in 1.5 years, surpassing expectations, but now trades at a premium valuation. Despite strong earnings and growth, Cabot's current valuation limits its upside, making it a "Hold" with a price target of $115/share. The company's fundamentals are solid, but market-beating returns are unlikely at current levels, prompting consideration for rotation into undervalued stocks. Cabot fulfills quality criteria but fails on valuation, justifying a cautious stance and potential sale above $115/share. Read the full article on Seeking AlphaArticle d’analyse • Oct 31
Here's Why We Think Cabot (NYSE:CBT) Might Deserve Your Attention Today
Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks...Article d’analyse • Oct 19
Is There Now An Opportunity In Cabot Corporation (NYSE:CBT)?
Cabot Corporation ( NYSE:CBT ), is not the largest company out there, but it led the NYSE gainers with a relatively...Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 9/30/2028 | 3,923 | N/A | 261 | 551 | 5 |
| 9/30/2027 | 3,796 | 378 | 252 | 517 | 6 |
| 9/30/2026 | 3,683 | 226 | 203 | 443 | 6 |
| 6/30/2026 | 3,634 | 187 | 281 | 497 | N/A |
| 3/31/2026 | 3,575 | 281 | 432 | 671 | N/A |
| 12/31/2025 | 3,607 | 306 | 401 | 667 | N/A |
| 9/30/2025 | 3,713 | 326 | 364 | 665 | N/A |
| 6/30/2025 | 3,815 | 418 | 321 | 650 | N/A |
| 3/31/2025 | 3,908 | 426 | 288 | 608 | N/A |
| 12/31/2024 | 3,991 | 417 | 420 | 711 | N/A |
| 9/30/2024 | 3,994 | 374 | 451 | 692 | N/A |
| 6/30/2024 | 3,958 | 470 | 399 | 626 | N/A |
| 3/31/2024 | 3,910 | 443 | 407 | 662 | N/A |
| 12/31/2023 | 3,924 | 433 | 385 | 648 | N/A |
| 9/30/2023 | 3,931 | 437 | 351 | 595 | N/A |
| 6/30/2023 | 4,078 | 300 | 306 | 562 | N/A |
| 3/31/2023 | 4,259 | 315 | 127 | 353 | N/A |
| 12/31/2022 | 4,318 | 348 | -15 | 201 | N/A |
| 9/30/2022 | 4,321 | 206 | -111 | 100 | N/A |
| 6/30/2022 | 4,113 | 142 | -106 | 95 | N/A |
| 3/31/2022 | 3,881 | 130 | -65 | 132 | N/A |
| 12/31/2021 | 3,631 | 98 | -9 | 187 | N/A |
| 9/30/2021 | 3,409 | 247 | 62 | 257 | N/A |
| 6/30/2021 | 3,164 | -54 | 103 | 256 | N/A |
| 3/31/2021 | 2,765 | -144 | 184 | 334 | N/A |
| 12/31/2020 | 2,633 | -219 | 132 | 293 | N/A |
| 9/30/2020 | 2,614 | -238 | 177 | 377 | N/A |
| 6/30/2020 | 2,782 | 65 | 244 | 475 | N/A |
| 3/31/2020 | 3,109 | 103 | N/A | 441 | N/A |
| 12/31/2019 | 3,243 | 127 | N/A | 507 | N/A |
| 9/30/2019 | 3,337 | 155 | N/A | 363 | N/A |
| 6/30/2019 | 3,360 | 217 | N/A | 321 | N/A |
| 3/31/2019 | 3,369 | 273 | N/A | 268 | N/A |
| 12/31/2018 | 3,343 | 77 | N/A | 214 | N/A |
| 9/30/2018 | 3,242 | -114 | N/A | 298 | N/A |
| 6/30/2018 | 3,115 | -136 | N/A | 300 | N/A |
| 3/31/2018 | 2,966 | -177 | N/A | 371 | N/A |
| 12/31/2017 | 2,826 | 69 | N/A | 286 | N/A |
| 9/30/2017 | 2,717 | 246 | N/A | 348 | N/A |
| 6/30/2017 | 2,613 | 225 | N/A | 288 | N/A |
| 3/31/2017 | 2,529 | 234 | N/A | 262 | N/A |
| 12/31/2016 | 2,419 | 209 | N/A | 416 | N/A |
| 9/30/2016 | 2,411 | 145 | N/A | 392 | N/A |
| 6/30/2016 | 2,463 | 136 | N/A | 516 | N/A |
| 3/31/2016 | 2,536 | -366 | N/A | 482 | N/A |
| 12/31/2015 | 2,662 | -388 | N/A | 526 | N/A |
| 9/30/2015 | 2,871 | -336 | N/A | 499 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: La croissance des bénéfices prévue de CBT ( 57.8% par an) est supérieure au taux d'épargne ( 3.7% ).
Bénéfices vs marché: Les bénéfices de CBT ( 57.8% par an) devraient croître plus rapidement que le marché US ( 17.1% par an).
Croissance élevée des bénéfices: Les bénéfices de CBT devraient augmenter de manière significative au cours des 3 prochaines années.
Chiffre d'affaires vs marché: Le chiffre d'affaires de CBT ( 3.7% par an) devrait croître plus lentement que le marché de US ( 13.3% par an).
Croissance élevée des revenus: Le chiffre d'affaires de CBT ( 3.7% par an) devrait croître plus lentement que 20% par an.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: Le retour sur capitaux propres de CBT devrait être élevé dans 3 ans ( 21.2 %)
Découvrir les entreprises en croissance
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/09/15 12:39 |
| Cours de l'action en fin de journée | 2026/09/15 00:00 |
| Les revenus | 2026/06/30 |
| Revenus annuels | 2025/09/30 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github ; nous proposons également des guides sur la façon d’utiliser nos rapports et des tutoriels sur YouTube.
Découvrez l' qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
Cabot Corporation est couverte par 11 analystes. 6 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Benjamin Kallo | Baird |
| Michael Leithead | Barclays |
| David Begleiter | Deutsche Bank |